Kolon Tissuegene INC
Clinical-stage bio-pharmaceutical company
Based in MD
🤖
AI Overview
With $370K in lobbying spend across 6 quarterly filings, Kolon Tissuegene INC is an active lobbying client. Their lobbying covers 2 issue areas.
$370K
Total Spend
1
Years Active
1
Firms Hired
3
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2024 | $370K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Aerospace
- •Support for the advancement of technologies in the biomedical and aeronautics industries
- •Introduce company and its technologies, and discuss opportunities for collaboration.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Lockheed Martin Corporation
$580K total spend
The Livingston Group (on Behalf of Kolon Tissuegene, INC.)
$120K total spend
International Association of Machinists and Aerospace Workers
$23.4M total spend
The American Occupational Therapy Association, INC. (Aota)
$6.0M total spend
United Assn of Journeymen & Apprentices of the Plumbing & Pipefitting Industry
$5.7M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.